Login/Sign Up
₹5651.85
(Inclusive of all Taxes)
Get Free delivery (₹99) with
Pemexar 500 mg Injection 1's is an injection used to treat certain types of cancers, such as non-small cell lung cancer and malignant pleural mesothelioma. It is a medical treatment designed to slow down or stop the growth of cancer cells in the body. By targeting these abnormal cells, the medicine helps manage the disease and prevent it from spreading further.
This medicine is given as an infusion into a vein on a schedule determined by your doctor, usually once every three weeks. Because it is given in a clinical setting by healthcare professionals, maintaining your scheduled appointments is vital for consistent results. Staying well-hydrated and eating balanced, small meals during your treatment cycle can support your body through therapy.
Common side effects of this treatment include fatigue, nausea, and low blood cell counts. You must contact your doctor immediately if you develop signs of an infection, such as a fever, or experience unusual bleeding and bruising. Your healthcare team will monitor your blood counts regularly to ensure it is safe for you to continue treatment.
Before you begin taking Pemexar 500 mg Injection 1's, tell your doctor if you have kidney disease, as this condition can affect how your body clears the medicine. Do not take this if you have had a severe allergic reaction to this medicine or any of its ingredients. It is also important to share your complete medical history with your oncologist before your first session.
Certain medicines, such as nonsteroidal anti-inflammatory drugs (NSAIDs), can interact with Pemexar 500 mg Injection 1's and increase your risk of severe side effects. Avoid alcohol and smoking during treatment, as they can place extra strain on your liver and worsen fatigue. If you are pregnant, planning to become pregnant, or breastfeeding, you should not take this medicine, and elderly patients may require closer monitoring of their kidney function.
Pemexar 500 mg Injection 1's is used to treat certain types of cancers. The detailed uses of Pemexar 500 mg Injection 1's are as follows:
Pemexar 500 mg Injection 1's helps treat certain types of cancer by slowing the growth and spread of cancer cells. With regular use as prescribed, it helps control disease progression, relieve tumour-related symptoms, and support long-term treatment outcomes.
Consult your doctor
It is not known if alcohol affects Pemexar 500 mg Injection 1's. Please consult your doctor.
Unsafe
Pemetrexed belongs to pregnancy category D. The use of Pemexar 500 mg Injection 1's should be avoided during pregnancy as it might harm the unborn baby.
Unsafe
Breastfeeding must be discontinued during treatment with Pemexar 500 mg Injection 1's.
Caution
Pemexar 500 mg Injection 1's may cause tiredness. Caution is advised while driving or operating heavy machinery.
Consult your doctor
If you have a history of liver disease, inform your doctor before receiving Pemexar 500 mg Injection 1's.
Caution
Dose adjustment may be needed. If you have a history of kidney disease, inform your doctor before receiving Pemexar 500 mg Injection 1's.
Unsafe
Pemexar 500 mg Injection 1's is not recommended for children below 18 years as safety and effectiveness have not been established.
Consult your doctor
Please consult your doctor if you have any heart problems before taking Pemexar 500 mg Injection 1's.
Consult your doctor
Please consult a doctor before administering Pemexar 500 mg Injection 1's to geriatric patients. Your doctor will prescribe Pemexar 500 mg Injection 1's if the benefits outweigh the risks.
Have a query?
The time required for Pemexar 500 mg Injection 1's to start to work: The time required for Pemexar 500 mg Injection 1's to show its action is not clinically established. The time for which the effects of Pemexar 500 mg Injection 1's last: The effect of Pemexar 500 mg Injection 1's lasts for 6 to 9 hours.
Login/Sign Up
No clinically significant food interactions are known with Pemexar 500 mg Injection 1's when used as directed.
Login/Sign Up
Disclaimer
